glp-1 news today 2025 november 5 In U.S., Usage Reaches New High Beyond GLP-1: the next wave

The decision came only a few months after a separate North Carolina agency announced it would start covering these drugs for Medicaid beneficiaries

Gastroparesis patients endure persistent nausea, severe abdominal cramping, repeated vomiting episodes disrupting daily activities, and malnutrition from inability to properly digest food

In recent years, the agency has been aggressive in pursuing enforcement actions against companies that engage in unlawful promotion of off-label drug use

Residents see that progress is possible without extreme measures or frustration

But representatives for Altimmune say its drug may mimic the beneficial effects of weightlifting without making you do the work